Dr. Bradley Kincaid Hertzler, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2 W 42nd St Ste 3100, Scottsbluff, NE 69361 Phone: 308-632-2872 |
Jason Latowsky, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2 W 42nd St, Ste 3100, Scottsbluff, NE 69361 Phone: 308-632-2879 Fax: 308-632-4191 |
Dr. Kelly Joseph Casey, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1000 Pole Creek Crossing, Sidney, NE 69162 Phone: 308-254-5825 |
Dr. James D Thayer, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 1000 Pole Creek, Sidney, NE 69162 Phone: 308-254-7268 Fax: 308-254-8722 |
Dr. Morris C. Benson, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 510 N Green St, Valentine, NE 69201 Phone: 402-376-2525 Fax: 402-376-1627 |
Dr. Daniel John Growney, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2114 N Lincoln Ave, Suite B, York, NE 68467 Phone: 402-362-4339 Fax: 402-362-7743 |
Dr. Ye Ye, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2114 N Lincoln Ave, Suite B, York, NE 68467 Phone: 402-362-4339 Fax: 402-362-7743 |
News Archive
Findings from a new cancer study may seem obvious — a patient's overall health is a critical factor in assessing prognosis. But the study's authors say data about patients' non-cancer ailments, called comorbidities, are not currently incorporated into cancer statistics.
Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells, a biological insurance policy for families nationwide and internationally, said today that it is on schedule to complete the construction of its new Las Vegas laboratory by the first week of October.
Like breathing or blinking, behaviors regulated by our circadian rhythms, such as digestion and sleep-wake cycles, go unnoticed by most people.
AMRI today announced that it has signed a definitive agreement to acquire all the outstanding shares of Cedarburg Pharmaceuticals, Inc. for $38.2 million in cash.
› Verified 2 days ago